Pentavalent human-bovine (WC3) reassortant rotavirus vaccine in special populations: A review of data from the Rotavirus Efficacy and Safety Trial

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 27, Issue 7, 2008, Pages 495-501

  Van Der Wielen, M ^a   Van Damme, P ^a  

^a UNIVERSITY OF ANTWERP   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

PLACEBO; ROTAVIRUS VACCINE;

APNEA ATTACK; BREAST FEEDING; BRONCHIOLITIS; CLINICAL TRIAL; DIARRHEA; DISEASE COURSE; DRUG EFFICACY; DRUG SAFETY; FEVER; GASTROENTERITIS; GENETIC REASSORTMENT; GESTATIONAL AGE; HEALTH CARE ORGANIZATION; HUMAN; IMMUNOCOMPROMISED PATIENT; INTUSSUSCEPTION; IRRITABILITY; MORBIDITY; MORTALITY; OUTCOME ASSESSMENT; PNEUMONIA; PRACTICE GUIDELINE; PREMATURITY; PRIORITY JOURNAL; REVIEW; ROTAVIRUS; SIDE EFFECT; UNSPECIFIED SIDE EFFECT; VIRUS INFECTION; VIRUS SHEDDING; VOMITING;

BREAST FEEDING; CHILD, PRESCHOOL; CLINICAL TRIALS AS TOPIC; HUMANS; INFANT; INFANT, NEWBORN; INFANT, PREMATURE; PRACTICE GUIDELINES AS TOPIC; ROTAVIRUS INFECTIONS; ROTAVIRUS VACCINES;

EID: 45449090414     PISSN: 09349723     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10096-008-0479-5     Document Type: Review

References (43)

1. Fischer TK, Bresee JS, Glass RI (2004) Rotavirus vaccines and the prevention of hospital-acquired diarrhea in children. Vaccine 22(Suppl 1):S49-S54
2. Chen SM, Ni YH, Chen HL, Chang MH (2006) Microbial etiology of acute gastroenteritis in hospitalized children in Taiwan. J Formos Med Assoc 105:964-970
3. Colomba C, De Grazia S, Giammanco GM, Saporito L, Scarlata F, Titone L, Arista S (2006) Viral gastroenteritis in children hospitalized in Sicily, Italy. Eur J Clin Microbiol Infect Dis 25:570-575
4. Bresee JS, Glass RI, Ivanoff B, Gentsch JR (1999) Current status and future priorities for rotavirus vaccine development, evaluation and implementation in developing countries. Vaccine 17:2207-2222
5. Kurugol Z, Geylani S, Karaca Y, Umay F, Erensoy S, Vardar F, Bak M, Yaprak I, Ozkinay F, Ozkinay C (2003) Rotavirus gastroenteritis among children under five years of age in Izmir, Turkey. Turk J Pediatr 45:290-294
6. Bresee JS, Parashar UD, Widdowson MA, Gentsch JR, Steele AD, Glass RI (2005) Update on rotavirus vaccines. Pediatr Infect Dis J 24:947-952
7. Parashar UD, Glass RI (2006) Progress toward rotavirus vaccines. Science 312:851-852
8. Parashar UD, Gibson CJ, Bresee JS, Glass RI (2006) Rotavirus and severe childhood diarrhea. Emerg Infect Dis 12:304-306
9. Parashar UD, Hummelman EG, Bresee JS, Miller MA, Glass RI (2003) Global illness and deaths caused by rotavirus disease in children. Emerg Infect Dis 9:565-572
10. Soriano-Gabarró M, Mrukowicz J, Vesikari T, Verstraeten T (2006) Burden of rotavirus disease in European Union countries. Pediatr Infect Dis J 25:S7-S11
11. Centers for Disease Control and Prevention (1998) Laboratory-based surveillance for rotavirus: United States, July 1997-June 1998. MMWR Morb Mortal Wkly Rep 47:978-980
12. Brandt CD, Kim HW, Yolken RH, Kapikian AZ, Arrobio JO, Rodriguez WJ, Wyatt RG, Cahnock RM, Parrott RH (1979) Comparative epidemiology of two rotavirus serotypes and other viral agents associated with pediatric gastroenteritis. Am J Epidemiol 110:243-254
13. Bishop RF, Barnes GL, Cipriani E, Lund JS (1983) Clinical immunity after neonatal rotavirus infection. N Engl J Med 309:72-76
14. American Academy of Pediatrics Committee on Infectious Diseases (2007) Prevention of rotavirus disease: guidelines for use of rotavirus vaccine. Pediatrics 119:171-182
15. Ford T (2006) Emerging issues in water and health research. J Water Health 4(Suppl 1):59-65
16. Sharma R, Hudak ML, Premachandra BR, Stevens G, Monteiro CB, Bradshaw JA, Kaunitz AM, Hollister RA (2002) Clinical manifestations of rotavirus infection in the neonatal intensive care unit. Pediatr Infect Dis 21:1099-1105
17. Newman RD, Grupp-Phelan J, Shay DK, Davis RL (1999) Perinatal risk factors for infant hospitalization with viral gastroenteritis. Pediatrics 103:E3
18. Dennehy PH, Cortese MM, Beque RE, Jaeger JL, Roberts NE, Zhang R, Rhodes P, Gentsch J, Ward R, Bernstein DI, Vitek C, Bresee JS, Staat MA (2006) A case-control study to determine risk factors for hospitalization for rotavirus gastroenteritis in U.S. children. Pediatr Infect Dis J 25:1123-1131
19. Liakopoulou E, Nutton K, Carrington D, Robinson S, Steward CG, Goulden NJ, Cornish JM, Marks DI (2005) Rotavirus as a significant cause of prolonged diarrhoeal illness and morbidity following allogeneic bone marrow transplantation. Bone Marrow Transplant 36:691-694
20. Saulsbury FT, Winkelstein JA, Yolken RH (1980) Chronic rotavirus infection in immunodeficiency. J Pediatr 97:61-65
21. Albano F, Bruzzese E, Bella A, Cascio A, Titone L, Arista S, Izzi G, Virdis R, Pecco P, Principi N, Fontana M, Guarino A (2007) Rotavirus and not age determines gastroenteritis severity in children: a hospital-based study. Eur J Pediatr 166:241-247
22. Banerjee I, Ramani S, Primrose B, Moses P, Iturriza-Gomara M, Gray JJ, Jaffar S, Monica B, Muliyil JP, Brown DW, Estes MK, Kang G (2006) Comparative study of the epidemiology of rotavirus in children from a community-based birth cohort and a hospital in South India. J Clin Microbiol 44:2468-2474
23. Gianino P, Mastretta E, Longo P, Laccisaglia A, Sartore M, Russo R, Mazzaccara A (2002) Incidence of nosocomial rotavirus infections, symptomatic and asymptomatic, in breast-fed and non-breast-fed infants. J Hosp Infect 50:13-17
24. Sterling LM, Richardson J, Ellis M (2003) Clinical inquiries. Does breastfeeding protect against viral GI infections in children <2 years old? J Fam Pract 52:805-806
25. Greenberg HB, Clark HF, Offit PA (1994) Rotavirus pathology and pathophysiology. Curr Top Microbiol Immunol 185:255-283
26. Raebel MA, Ou BS (1999) Rotavirus disease and its prevention in infants and children. Pharmacotherapy 19:1279-1295
27. Velazquez FR, Matson DO, Calva JJ, Guerrero L, Morrow AL, Carter-Campbell S, Glass RI, Estes MK, Pickering LK, Ruiz-Palacios GM (1996) Rotavirus infections in infants as protection against subsequent infections. N Engl J Med 335:1022-1028
28. RotaTeq (rotavirus vaccine, live, oral, pentavalent) (2007) Product information. Merck & Co., Inc., Whitehouse Station, NJ, USA
29. RotaTeq (oral solution, rotavirus vaccine [live, oral]) (2007) Summary of product characteristics. Sanofi Pasteur MDS, SNC, Lyon, France
30. Rotarix (powder and solvent for oral suspension) (2007) Summary of product characteristics. GlaxoSmithKline Biologicals s.a., Rixensart, Belgium
31. Van Damme P on behalf of ESPID-ESPGHAN Rotavirus Expert Group (2007) Evidence-based recommendations for the use of rotavirus vaccines in Europe (abstract). Presented at the 25th Annual Meeting of the European Society for Paediatric Infectious Diseases, Porto, Portugal, 2-4 May
32. Parashar UD, Alexander JP, Glass RI, Advisory Committee on Immunization Practices (ACIP) (2006) Prevention of rotavirus gastroenteritis among infants and children. Recommendation of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 55(RR-12):1-13
33. Parashar UD, Bresee JS, Gentsch JR, Glass RI (1998) Rotavirus. Emerg Infect Dis 4:561-570
34. Cook SM, Glass RI, LeBaron CW, Ho MS (1990) Global seasonality of rotavirus infections. Bull World Health Organ 68:171-177
35. Sharma R, Garrison RD, Tepas III JJ, Mollitt DL, Pieper P, Hudak ML, Bradshaw JA, Stevens G, Premachandra BR (2004) Rotavirus-associated necrotizing enterocolitis: an insight into a potentially preventable disease? J Pediatr Surg 39:453-457
36. Troussard X, Bauduer F, Gallet E, Freymuth F, Boutard P, Ballet JJ, Reman O, Leporrier M (1993) Virus recovery from stools of patients undergoing bone marrow transplantation. Bone Marrow Transplant 12:573-576
37. Yolken RH, Bishop CA, Townsend TR, Bolyard EA, Bartlett J, Santos GW, Saral R (1982) Infectious gastroenteritis in bone-marrow-transplant recipients. N Engl J Med 306:1010-1012
38. Centers for Disease Control and Prevention (2007) Advisory Committee on Immunization Practices. Record of the proceedings, 27-28 June
39. Vesikari T, Matson DO, Dennehy P, Van Damme P, Santosham M, Rodriguez Z, Dallas MJ, Heyse JF, Goveia MG, Black SB, Shinefield HR, Chrisite CDC, Ylitalo S, Itzler RF, Coia ML, Onorato MT, Adeyi BA, Marshall GS, Gothefors L, Campens D, Karvonen A, Watt JP, O'Brien KL, DiNubile MJ, Clark HF, Boslego JW, Offit PA, Heaton PM, Rotavirus Efficacy and Safety Trial (REST) Study Team (2006) Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine. N Engl J Med 354:23-33
40. Goveia MG, Rodriguez ZM, Dallas MJ, Itzler RF, Boslego JW, Heaton PM, DiNubile MJ, REST Study Team (2007) Safety and efficacy of the pentavalent human-bovine (WC3) reassortant rotavirus vaccine in healthy premature infants. Pediatr Infect Dis J 26:1099-1104
41. Jackson KM, Nazar AM (2006) Breastfeeding, the immune response, and long-term health. J Am Osteopath Assoc 106:203-207
42. Greenberg DP, Vadheim CM, Partridge S, Chang SJ, Chiu CY, Ward JI (1994) Immunogenicity of Haemophilus influenzae type b tetanus toxoid conjugate vaccine in young infants. The Kaiser-UCLA Vaccine Study Group. J Infect Dis 170:76-81
43. Pichichero ME (1990) Effect of breast-feeding on oral rhesus rotavirus vaccine seroconversion: a meta-analysis. J Infect Dis 162:753-755